相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Risk factors for vertebral fractures and bone loss after denosumab discontinuation: A real-world observational study
J. Everts-Graber et al.
BONE (2021)
Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption (vol 184, pg 1330, 2021)
Michelle M. McDonald et al.
CELL (2021)
Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases
Peter Burckhardt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its Discontinuation
Polyzois Makras et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates
P. D. Miller et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed
Serge Ferrari et al.
BONE (2020)
Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment
Serge Ferrari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
Steven R. Cummings et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)